Seelos therapeutics to participate in the 3rd international conference on sanfilippo syndrome and related diseases

New york, nov. 9, 2020 /prnewswire/ -- seelos therapeutics, inc. (nasdaq: seel), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in the 3rd international...
SEEL Ratings Summary
SEEL Quant Ranking